Fig. 1From: Empagliflozin in kidney transplant recipients with chronic kidney disease G3a-4 and metabolic syndrome: Five Japanese casesClinical course of Case1. In case 1, HbA1c and UACR increased and decreased with changes in body weight. There was no change in renal function during the course.Back to article page